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Abstract
Objectives:  To assess the effect of variations in GTP cyclohydrolase gene (GCH1) on pain
sensitivity in humans.
Methods: Thermal and cold pain sensitivity were evaluated in a cohort of 735 healthy volunteers.
Among this cohort, the clinical pain responses of 221 subjects after the surgical removal of
impacted third molars were evaluated. Genotyping was done for 38 single nucleotide
polymorphisms (SNPs) whose heterozygosity > 0.2 in GCH1. Influence of the genetic variations
including SNPs and haplotypes on pain sensitivity were analyzed.
Results:  Minor allele frequencies and linkage disequilibrium show significant differences in
European Americans, African Americans, Hispanic Americans and Asian Americans. Association
analyses in European Americans do not replicate the previously reported important influence of
GCH1 variations on pain sensitivity.
Conclusion:  Considering population stratification, previously reported associations between
GCH1 genetic variations and pain sensitivity appear weak or negligible in this well characterized
model of pain.
Background
The role of 6(R)-t-erythro-5,6,7,8-tetrahydrobiopterin
(BH4) in pain is suggested by the up-regulation of two of
the three enzymes in the synthesis cascade of BH4 in the
dorsal root ganglion following sciatic nerve injury [1].
GTP cyclohydrolase (GCH) catalyzes the rate limiting
step, and sepiapterin reductase catalyzes the final conver-
sion of 6-pyruvoyltetrahydropterin to the BH4. It was
recently reported that single nucleotide polymorphisms
(SNPs) in the gene encoding GCH (GCH1) alter both
responses in healthy humans to noxious stimuli and the
susceptibility of patients to development of neuropathic
and inflammatory pain [2]. The authors also suggest a
pain protective haplotype associated with the risk of
developing persistent pain syndromes, which could be a
useful tool to assess an individual's risk potential for
chronic pain [2]. Based on this reported role of GCH in
pain both in animals and humans, we investigated its con-
tribution to genetic inter-individual variation in clinical
pain sensitivity and analgesic responses. We have investi-
gated the association between pain responses to experi-
mental and clinical painful stimuli and genetic variations
including SNPs and haplotypes of GCH1.
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Results
The minor allelic frequencies of each SNP in the GCH1 are
shown in Table 1.
We next determined what haplotypes are formed by these
SNPs. The total number of haploblocks found were 3 in
European Americans (average minimum span = 24.0 kb)
with 12 tag SNPs, 5 haploblocks with 21 tag SNPs in Afri-
can Americans (average minimum span = 5.3 kb), 3 hap-
loblocks with 14 tag SNPs in Hispanic Ameicans (average
minimum span = 22.7 kb) and 4 haploblocks with 10 tag
SNPs in Asian Americans (average minimum span = 16.1
kb). Position of those SNPs and haploblocks within the
loci of GCH1 are shown in Figure 1, 2, 3 and 4. Their D'
with confidence intervals and r2 matrices in each ethnic
population show large differences (see Additional file 1).
Further haploblock analysis was performed with Euro-
pean Americans only due to the small number of other
ethnic populations. We found 3 haploblocks from GCH1
(4 SNPs spanning ~17.4 kb, 5 SNPs spanning ~3.7 kb and
29 SNPs spanning ~51.0 kb respectively) based on the
confidence interval method.
In the GCH1 haploblock 1, a total of 5 haplotypes were
detected for the 4 SNPs, with the most frequent haplotype
(55.4%) composed of A_G_T_C. The 3 frequent haplo-
types (> 5%) were 98% of total haplotypes. In the GCH1
haploblock 2, a total of 7 haplotypes were detected for the
5 chosen SNPs, with the most frequent haplotype
(55.0%) composed of A_A_T_C_C. Four of the 7 haplo-
types were frequent (> 5%), and these 4 haplotypes were
99% of the total haplotypes. In the GCH1 haploblock 3, a
Table 1: SNPs genotyped in GCH1
Order SNP ID Location from transcription site Nucleotide variation Rarer allele frequency
1 rs8008858 -9,686 A/T 0.28
2 rs8007267 -9,462 G/A 0.28
3 rs2878172 -4,141 T/C 0.44
4 rs8017210 7,694 C/T 0.21
5 rs3783642 9,327 A/G 0.48
6 rs3783641 9,391 A/T 0.21
7 rs7147201 10,653 T/C 0.27
8 rs7147286 10,865 C/T 0.42
9 rs17128052 13,005 C/G 0.18
10 rs998259 14,499 G/A 0.14
11 rs10498471 15,813 C/T 0.22
12 rs8020798 16,162 G/A 0.21
13 rs8004018 18,834 T/C 0.25
14 rs8004445 18,864 C/A 0.25
15 rs3783639 20,864 A/G 0.20
16 rs3783638 21,157 C/T 0.26
17 rs3783637 21,412 G/A 0.18
18 rs10133650 23,257 G/C 0.47
19 rs12147422 25,515 A/G 0.25
20 rs17128050 25,651 A/G 0.17
21 rs7492600 32,655 C/A 0.26
22 rs2183081 32,779 T/C 0.47
23 rs8010282 39,275 T/C 0.21
24 rs9671455 40,450 G/C 0.26
25 rs9671371 40,895 G/A 0.33
26 rs2878169 43,537 C/A 0.06
27 rs12589758 43,668 T/A 0.22
28 rs12587434 43,947 A/C 0.23
29 rs7155309 46,679 C/T 0.27
30 rs2878168 48,745 A/G 0.22
31 rs4411417 48,967 A/G 0.22
32 rs10133662 53,260 T/C 0.39
33 rs10131232 53,622 C/T 0.40
34 rs752688 57,961 G/A 0.23
35 rs841 59,038 C/T 0.23
36 rs7142517 62,726 G/T 0.28
37 rs10483639 63,073 C/G 0.26
38 rs2057369 65,469 C/T 0.22Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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total of 17 haplotypes were detected for the 29 SNPs, with
the most frequent haplotype (28.7%) and 5 frequent hap-
lotypes were 88% of the total haplotypes. In the whole
GCH1, 12 SNPs were tag SNPs European American popu-
lation. Among 25 existing combinations of those 12 tag
SNPs, the most frequent combination occupies 28.3%
while 5 frequent (> 5%) combinations of tag SNPs are
87% of the total tag SNPs combinations (Table 2).
Considering the relatively dominating effect of gender on
pain, male and female subjects were analyzed separately
for the association between genetic variations (individual
SNPs and combination of haplotypes) and responses to
experimental and clinical painful stimuli. However, we
could not find any significant genetic associations
between variations of GCH1 including SNPs and haplo-
types and pain sensitivity or analgesic responses in this
cohort of European American females and males even
without multiple testing corrections. Figure 5 shows an
example of non-significant association between GCH1
genetic variations and pain sensitivity in European Amer-
ican females (GCH1 tag SNP combinations and heat and
cold pain ratings).
Discussion
We could not repeat any of the finding reported for
humans by Tegeder et al. First, the linkage disequilibrium
(LD) between SNPs and patterns of haplotype blocks in
our sample are not consistent with their previous finding
reporting one single block for GCH1. This inconsistency
may be caused by the samples evaluated and the atypical
interpretation of their data. The University of North Caro-
lina and University of Florida cohorts of Tegeder et al. cite
previous publications[3,4] with mixed population groups
and leave open the question whether their present study is
using mixed ethnicity groups as well. It has been shown
that the ethnic demographics can have profound influ-
ence on LD between SNPs, haploblock structure, SNP fre-
quency, and estimated effect size drawn from the data. It
is for these very reasons that haplotype data are reported
separately by ethnicity in the HapMap Project database.
When we analyzed haplotypes from our samples and the
HapMap website within the same region using Haplov-
iew, we obtained different haplotype blocks between each
ethnic groups, regardless of the algorithm used (imple-
mented in Haploview, confidence interval, 4-gamete and
Linkage disequilibrium of GCH1 in European Americans (Haploview results with confidence interval method) Figure 1
Linkage disequilibrium of GCH1 in European Americans (Haploview results with confidence interval method).Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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solid spine method). Ethnic differences in the structure of
haplotypes are consistent with other reports [5,6]. The sin-
gle large 72 kb block identified by Tegeder et al for GCH1
with 168 Caucasian chronic lumbar root pain subjects is
not consistent with the HapMap Caucasians (CEU),
which may reflect a lack of generalizability for the Tegeder
et al results. It is unclear how the data from the other
cohorts is affected by one single large haploblock gener-
ated from the back pain study, especially when that one
large block is not observed in the Phase II data released by
the HapMap project. We found 3 haplotype blocks across
GCH1 including its flanking region based on confidence
interval method in European Americans and 5 blocks in
African Americans with different size and different con-
tributing SNPs. Hispanic Americans and Asian Americans
also show unique haplotype blocks and LD values
between each SNPs in GCH1. These results are similar to
HapMap data and the general concept of smaller block
size in samples of African ancestry.
Additionally, Tegeder et al proposed the low minor allele
frequencies of a few markers as the cause of the disruption
of the LD. However, almost 0 values of D' were obtained
between 3 most frequent SNPs (10374 c>t as 29.69%, -
4289 t>c as 37.42% and 3932 g>t as 35.76% in their
minor allele frequencies) in supplementary figure 4 and
supplementary table table 2 in Tegeder et al. The authors
seem to interpret their data completely opposite direction.
Unique haplotype patterns including block size, block
numbers, contributing SNPs, tag SNPs along with LDs
acquired in each ethnic population in our sample are con-
sistent with HapMap data and clearly suggest that haplo-
type analysis with mixed population be avoided.
Using a mixed ethnic sample may also induce population
stratification. This can cause false associations since the
pattern of genetic variations as well as pain rating is not
uniform between ethnic populations [7], requiring use of
homogenous population in genetic association studies
[8]. Considering significant differences of allele frequen-
cies and pain sensitivities among ethnic populations, it
would be more informative to analyze single ethnic origin
population only compared to the total mixed sample to
determine if the apparent association is due to population
stratification.
Another possible reason of inconsistency is the pain phe-
notype. Because responses to different types of painful
stimuli are genetically dissociable [9], GCH1 genetic vari-
ation may affect the responses to a specific type of painful
stimulus, while not influencing other types of stimuli.
However, Tegeder et al. used Z score for their analyses for
Linkage disequilibrium of GCH1 in African Americans (Haploview results with confidence interval method) Figure 2
Linkage disequilibrium of GCH1 in African Americans (Haploview results with confidence interval method).Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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a chimeric phenotype that combines pain threshold and
pain tolerance, outcome measures at opposite ends of the
sensory continuum. Use of an artificial outcome measure
that has been transformed may not be an appropriate
physiological representative of pain sensation and could
potentially result in an artificial genetic association. Con-
sidering the non-significant association between GCH1
genetic variations and similar thermal pain sensitivity in
our sample, the inconsistency cannot be easily explained
by the differences in stimulus modalities. Additionally,
the Z score is based on the assumption that the variables
follow normal distribution, which pain as a phenotype
does not [10]. Since the Z score is calculated by the mean
and standard deviation, it would increase the risk of error
when samples come from different means and standard
deviations. Experimental heat pain threshold and toler-
ance have been reported that Caucasians have different
means and standard deviations from African ancestry
population.
It is also possible that our results may be false-negative.
Many phenotypes with modest estimated genetic effects
may result in false negative due to its underpowered stud-
ies and probably contribute to inconsistent replication.
There are probably many common variants in the human
genome with modest but real effects on common disease
risk, requiring large samples to convincingly identify such
variants [11]. Given these questions of study design
related to population stratification, haploblock size, and
disparate pain measures in Tegeder et al with similar sta-
tistical power of our samples, it is more probable that this
association between GCH1  genetic variations and pain
sensitivity are, if any, weak or negligible regardless of their
strong in vitro and animal findings.
It is doubtful that a single gene accounting for large por-
tion of the variability can explain the polygenic nature of
pain. In many genetic association studies, true positive
associations are rare, and most of the "significant" results
rarely represent a true-positive association for which the
genetic effect is accurately estimated [11]. Considering the
overwhelming size of the human genome and relatively
high risk of potential flaws in study design and analysis of
complicated new methodology [12], replication of the
association with independent population samples from
studies strictly observing rules of genetic research is critical
[13].
Conclusion
Considering population stratification, previously
reported associations between GCH1  genetic variations
Linkage disequilibrium of GCH1 in Hispanic Americans (Haploview results with confidence interval method) Figure 3
Linkage disequilibrium of GCH1 in Hispanic Americans (Haploview results with confidence interval method).Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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and pain sensitivity appear weak or negligible in this well
characterized model of pain.
Methods
Subjects
Normal subjects (443 females and 292 males) were eval-
uated following informed consent under a human
research protocol approved by the IRB. Demographics
and characteristics of the cohort were previously described
[14]. Briefly, subjects were not experiencing any clinical
pain as symptomatic patients were referred elsewhere at
the time of initial screening. Self reported ethnicity in the
sample was 50.1% European American, 22.8% African
American, 10.6% Hispanic, and 14.1% Asian American in
composition. For the genotype linkage, we excluded indi-
viduals with mixed race parentage (2.3%).
Among 735 subjects, 221 patients underwent standard-
ized surgery by the same oral surgeon removing third
molar teeth that included at least one bony impacted
mandibular third molar [15]. After receiving pre-medica-
tion with intravenous midazolam (4.9 ± 0.2 mg) and local
anesthesia with 2% lidocaine (250.6 ± 43.0 mg) with
epinephrine 1:100,000, a mucoperiosteal flap was raised
and retracted, bone removed, and the teeth were sectioned
as needed to facilitate extraction of the impacted lower
third molars.
SNP genotyping
For genotyping, 50 ml of venous blood from each subject
was collected. DNA isolation was performed with the
Puregene™ DNA isolation kit (Gentra Systems Inc., Min-
neapolis, Minnesota, USA) following manufacturer's
instructions.
For SNP genotyping, Assays-on-Demand or Assays-by-
Design SNP Genotyping Products (Applied Biosystems,
Foster City, California, USA) were used. Each well con-
tained 2.5 μl of Taqman universal master mix, 0.25 μl of
genotyping assay mix and 2.25 μl of DNAse free water.
Polymerase chain reaction (PCR) was performed under
the following conditions: 95°C, 10 min followed by 40
cycles of 92°C, 15 seconds and 60°C, 1 minute in a Per-
kin-Elmer™ 9700 thermocycler (Perkin-Elmer Inc., Bos-
ton, Massachusetts, USA). Following PCR, fluorescence of
each well was measured using the ABI Prism 7900
Sequence Detection System (Applied Biosystems, Foster
City, California, USA). From the genomic sequences
including their flanking regions, 38 SNPs (heterozygosity
> 0.2, average distance = 2.0 kb) from GCH1 (genomic
Linkage disequilibrium of GCH1 in Asian Americans (Haploview results with confidence interval method) Figure 4
Linkage disequilibrium of GCH1 in Asian Americans (Haploview results with confidence interval method).Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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size = 75 kbs including flanking region) were screened.
Detailed information of genotyped SNPs is in Table 1.
Genotype discrimination was performed using Taqman
Sequence Detector version 2.1 software. Samples that
failed to amplify were not included in the final analysis.
Experimental pain sensitivity measurements
We measured pain sensitivity in response to experimental
painful thermal stimuli and cold stimuli with separate vis-
ual analogue scale (VAS) ratings for pain intensity. Indi-
viduals were trained to use a sliding VAS by rating a visual
gray scale. This procedure also provides an indication of
each subject's comprehension of the rating process using
a VAS [16]. For cold stimuli, we recorded cold pain inten-
sity (CPI) VAS ratings every 30 seconds following submer-
sion of the subject's hand up to the wrist into an insulated
bucket filled with iced-water (2–4°C). We instructed sub-
jects to keep their hand submerged while clenching and
unclenching repeatedly to prevent local warming in the
water until the pain reached an "unbearable level" or 180
seconds, whichever occurred soonest. The temperature of
iced water was maintained by ice cubes separated from the
subject's hand by a wire mesh. Subjects rated CPI at 30
seconds, if they withdrew their hand prior to 30 seconds,
CPI was rated at their cold withdrawal time (CWT).
Individuals rated heat pain intensity (HPI) using a VAS
following application of 35, 43, 44, 45, 46, 47, and 49°C
thermal stimuli for 5 seconds. The thermode probe area
was 1 cm in diameter and mounted in a housing to main-
tain constant pressure with the skin. The probe was self-
applied at six different sites on the volar forearm within an
area of ~40 × 100 mm. Four iterations were completed for
each temperature by moving the probe from spot to spot
to eliminate the possibility of sensitization or tissue dam-
age. The order of each temperature was pre-determined
for each trial, but the order was quasi-random to prevent
subjects from anticipating each subsequent stimulus. Sub-
jects were blinded with regard to the temperature of the
stimulus.
Clinical Pain measurement
Clinically induced pain was recorded with a paper and
pencil form of a 100 mm VAS. After the extraction of the
impacted third molars, pain was recorded every 20 min-
utes by VAS until subjects requested analgesic medication
as the local anesthesia was eliminated and post-operative
pain onset occurred. Ketorolac tromethamine (Toradol)
was administered intravenously at the recommended
dose (30 mg) and pain was recorded by VAS again at 15
minutes interval for 180 minutes. The maximum post-
operative pain rating, onset time of post-operative pain,
the analgesic onset time after medication and pain relief
at 180 minutes after medication were used as measures of
clinical pain.
Data analysis
To resolve phase unknown genotypes and estimate popu-
lation frequencies in unrelated individuals we employed
PHASE method, a probability based Bayesian algorithm.
Haploblocks based on confidence interval rule [5] were
Table 2: Frequent haploblocks of GCH1 in European Americans
Haplotype Frequency
Haploblock 1 A_G_T_C 0.55
A_G_C_C 0.25
T_A_C_T 0.17
total 0.98
Haploblock 2 A_A_T_C_C 0.55
G_T_C_T_G 0.18
G_A_T_T_C 0.17
G_A_T_C_C 0.09
total 0.99
Haploblock 3 G_C_G_T_C_A_C_G_G_A_A_C_T_T_G_G_C_T_A_C_A_A_T_C_G_C_G_C_C 0.29
G_C_A_T_C_G_C_G_C_A_A_C_C_T_C_A_C_A_C_T_G_G_C_T_A_T_G_G_T 0.19
G_T_G_C_A_A_T_A_C_G_G_A_C_C_G_G_C_T_A_C_A_A_T_C_G_C_T_C_C 0.15
G_C_G_T_C_A_C_G_G_A_A_C_T_T_G_A_A_T_A_C_A_A_C_T_G_C_G_C_C 0.06
A_C_G_T_C_A_C_G_G_A_A_C_T_T_G_G_C_T_A_C_A_A_T_C_G_C_T_C_C 0.20
total 0.88
Tag SNPs A_T_C_A_A_C_G_C_G_G_G_G 0.28
A_T_C_A_A_C_A_C_G_G_G_T 0.19
T_C_T_G_T_T_G_C_A_C_A_G 0.16
A_C_C_G_A_T_G_T_G_C_G_T 0.15
A_C_C_G_A_C_G_C_G_G_A_G 0.08
total 0.87Molecular Pain 2007, 3:6 http://www.molecularpain.com/content/3/1/6
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generated by Haploview version 3.11. To quantify linkage
disequilibrium (LD), widely used D' and r2 were calcu-
lated. Both measures are built on the basic pairwise-dise-
quilibrium coefficient, D, which is the difference between
the probability of observing two marker alleles on the
same haplotype and observing them independently in the
population. A value of 0 implies independence, whereas
1.0 means complete co-transfer.
Due to the smaller sample size when subdivided into eth-
nic groups, second association analyses with experimental
and clinical pain was done only in European Americans.
For the associations between haplotypes, individual SNPs
and cold/heat pain sensitivity and/or clinical pain
responses, statistical evaluation was performed with anal-
ysis of variance (ANOVA) models. Groups of frequency
less than 5% were excluded for the association analyses.
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